Victoria Speed

12PUBLICATIONS
40CO-AUTHORS
Epidemiology not elsewhere classifiedPharmacogenomicsBusiness process managementVisual effectsHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Dec 17, 2025
Trends and variation in the use of andexanet alfa for the reversal of direct oral anticoagulants in NHS trusts in England.

Louis Fisher, Richard Buka, Rosalind Byrne

|Apr 08, 2024
OpenSAFELY: The impact of COVID-19 on azathioprine, leflunomide and methotrexate monitoring, and factors associated with change in monitoring rate.

Andrew D Brown, Louis Fisher, Helen J Curtis

|Mar 26, 2024
The impact of COVID-19 on medication reviews in English primary care. An OpenSAFELY-TPP analysis of 20 million adult electronic health records.

Christopher Wood, Victoria Speed, Louis Fisher

|Feb 01, 2024
Safety of direct-acting oral anticoagulant (DOAC) prescribing: OpenSAFELY-TPP analysis of 20.5 million adults' electronic health records.

Karen Homan, Rachel Seeley, Louis Fisher

|Nov 03, 2022
Pooled Analysis of Rivaroxaban therapy for acute venous thromboembolism in FIRST registry, SWIVTER and DRESDEN NOAC registry.

Stephanie Müller, Luise Tittl, Victoria Speed

|Dec 01, 2021
Adherence to rivaroxaban for the treatment of venous thromboembolism-Results from the FIRST registry.

Victoria Speed, Vivian Auyeung, Jignesh P Patel

Pageof 2

Frequent Collaborators

7 joint publications

Lara Roberts

5 joint publications

Jignesh P Patel

4 joint publications

Roopen Arya

3 joint publications

Andrew D Brown